Atyr Pharma Inc [NASDAQ: ATYR] jumped around 0.34 points on Wednesday, while shares priced at $5.53 at the close of the session, up 6.55%.
Atyr Pharma Inc stock is now 266.23% up from its year-to-date (YTD) trading value. ATYR Stock saw the intraday high of $5.58 and lowest of $5.07 per share. The company’s 52-week high price is 5.98, which means current price is +140.43% above from all time high which was touched on 06/10/25.
Compared to the average trading volume of 2.29M shares, ATYR reached a trading volume of 4356832 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Atyr Pharma Inc [ATYR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATYR shares is $19.35 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATYR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Atyr Pharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 18, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on January 06, 2025, representing the official price target for Atyr Pharma Inc stock. Previously, the target price had yet another raise to $17, while Wells Fargo analysts kept a Overweight rating on ATYR stock.
The Price to Book ratio for the last quarter was 6.56, with the Price to Cash per share for the same quarter was set at 0.86.
How has ATYR stock performed recently?
Atyr Pharma Inc [ATYR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.80. With this latest performance, ATYR shares gained by 2.79% in over the last four-week period, additionally plugging by 38.94% over the last 6 months – not to mention a rise of 52.76% in the past year of trading.
Atyr Pharma Inc [ATYR]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -60.25%, with Return on Assets sitting at -60.25%.
Insider trade positions for Atyr Pharma Inc [ATYR]
There are presently around $69.63%, or 71.22% of ATYR stock, in the hands of institutional investors.
